Amylopectin-based Hydrogel Probes for Brain-machine Interfaces

Area of Science:

• Biomaterials Science
• Neuroscience
• Medical Devices

Background:

• Traditional implantable neural probes face challenges in balancing sensitivity, biocompatibility, and in situ monitoring.
• Existing probes struggle with effective neural information acquisition and neuromodulation for brain disorders.

Purpose of the Study:

• To develop an advanced implantable hydrogel probe for neural signal recording, circuit modulation, and stroke treatment.
• To enhance probe sensitivity and biocompatibility using amylopectin-integrated hydrogels with poly(3,4-ethylenedioxythiophene) (PEDOT).

Main Methods:

• Integration of amylopectin into hydrogels to reorient poly(3,4-ethylenedioxythiophene) (PEDOT) chains for improved tissue interfacing.
• Continuous recording of deep brain signals in rats for 8 weeks.
• Neuromodulation and signal monitoring in the primary motor cortex of rats, including stroke models.

Main Results:

• The hydrogel probe demonstrated continuous deep brain signal recording for 8 weeks.
• Successful neuromodulation in the primary motor cortex enabled control over limb behaviors.
• Application in stroke models significantly reduced infarct area, promoted synaptic reorganization, and restored motor function.

Conclusions:

• The novel hydrogel neural probe offers enhanced sensitivity and biocompatibility for neural monitoring and neuromodulation.
• This technology shows significant therapeutic potential for brain disorders, including stroke recovery.
• Represents a breakthrough in designing neural probes for advanced brain interfacing and therapeutic interventions.